Y. H. Balcioglu Et Al. , "Hemoglobin A1c as a metabolic risk indicator for cardiovascular morbidity in schizophrenia," 29th Congress of the European-College-of-Neuropsychopharmacology (ECNP) , vol.26, Vienna, Austria, 2016
Balcioglu, Y. H. Et Al. 2016. Hemoglobin A1c as a metabolic risk indicator for cardiovascular morbidity in schizophrenia. 29th Congress of the European-College-of-Neuropsychopharmacology (ECNP) , (Vienna, Austria).
Balcioglu, Y. H., Kalelioglu, T., Durak, N., Karamustafalioglu, N., Genc, A., & Emul, M., (2016). Hemoglobin A1c as a metabolic risk indicator for cardiovascular morbidity in schizophrenia . 29th Congress of the European-College-of-Neuropsychopharmacology (ECNP), Vienna, Austria
Balcioglu, Y. Et Al. "Hemoglobin A1c as a metabolic risk indicator for cardiovascular morbidity in schizophrenia," 29th Congress of the European-College-of-Neuropsychopharmacology (ECNP), Vienna, Austria, 2016
Balcioglu, Y. H. Et Al. "Hemoglobin A1c as a metabolic risk indicator for cardiovascular morbidity in schizophrenia." 29th Congress of the European-College-of-Neuropsychopharmacology (ECNP) , Vienna, Austria, 2016
Balcioglu, Y. H. Et Al. (2016) . "Hemoglobin A1c as a metabolic risk indicator for cardiovascular morbidity in schizophrenia." 29th Congress of the European-College-of-Neuropsychopharmacology (ECNP) , Vienna, Austria.
@conferencepaper{conferencepaper, author={Y. H. Balcioglu Et Al. }, title={Hemoglobin A1c as a metabolic risk indicator for cardiovascular morbidity in schizophrenia}, congress name={29th Congress of the European-College-of-Neuropsychopharmacology (ECNP)}, city={Vienna}, country={Austria}, year={2016}}